]>
IRCT20200522047545N1 IRCT 2020-08-05 Tabriz University of Medical Sciences Evaluation of herbal compound containing Anacyclus pyrethrum, Senna, Ferrula asafoetida and Terminalia chebula in COVID19 Evaluation of herbal compound containing Anacyclus pyrethrum, Senna, Ferrula asafoetida and Terminalia chebula in COVID19: A randomized clinical trial study 2020-07-31 anticipated 200 Complete https://irct.ir/trial/48351 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: By visiting randomizer.org and selecting Generate numbers, 200 numbers in the range of 1000 to 100,000 will created for the list of patients. Then the odd or even numbers will be selected as the intervention group, Blinding description: The appearance of the placebo is formulated exactly like the main drug, so the patients will not be aware whether they are taking the original medicine or placebo. 2-3 COVID19. Intervention group: In addition to the standard treatment (200 mg Hydroxychloroquine tablets or two 250 mg Chloroquine phosphate tablets), herbal tablets containing Anacyclus pyrethrum, Senna, Ferrula asafoetida and Terminalia chebula will be taken in three tablets three times a day for 7 to 14 days.. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is It is confidential
public Ramin Mohammadzadeh
Daneshghah
Tabriz Iran (Islamic Republic of) 5164414766 +98 41 3334 9591 mohammadzadeh.ra@tbzmed.ac.ir Tabriz University of Medical Sciences scientific Mojtaba Varshouchi Fard
Daneshghah
Tabriz Iran (Islamic Republic of) 5164414766 +98 41 3337 0094 varshochim@tbzmed.ac.ir Tabriz University of Medical Sciences Iran (Islamic Republic of) Age: more than 18 Lab Analysis and CT-scan Patient consent The severity of the disease: mild to moderate 18 years no limit Both Patients with severe disease status Liver disease experience Pregnancy or breastfeeding Kidney failure Kidney transplantation experience Receiving any clinical trial medication in the last 30 days U07.1 COVID-19 Treatment - Drugs Intervention group: In addition to the standard treatment (200 mg Hydroxychloroquine tablets or two 250 mg Chloroquine phosphate tablets), herbal tablets containing Anacyclus pyrethrum, Senna, Ferrula asafoetida and Terminalia chebula will be taken in three tablets three times a day for 7 to 14 days. Decreasing hospital stay days. Timepoint: At the end of the study. Method of measurement: Based on the date of hospitalization and discharge from the hospital. Decreasing duration of symptoms presence. Timepoint: During and at the end of the study. Method of measurement: Based on the date of hospitalization and the date of dissolving of fever and improving of respiratory symptoms including dyspenea, cough and improving of O2 saturation during daily history taking and physical exams. Hospital care and treatment costs. Timepoint: At the end of the study. Method of measurement: Based on patients' financial records (hospital stay days and etc.). Tabriz University of Medical Sciences Approved 2020-05-18 Ethics Committee of Tabriz University of Medical Sciences Daneshghsh Tabriz East Azarbaijan Iran (Islamic Republic of)